Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats

Metabolic Brain Disease

Volumn 32, Issue 4, 2017, Pages 1279-1286

  Abdel Moneim, Adel ^a   Yousef, Ahmed I ^a   Abd El Twab, Sanaa M ^a   Abdel Reheim, Eman S ^a   Ashour, Mohamed B ^a  

^a Beni Suef University   (Egypt)

Author keywords

Gallic acid; Hippocampus; Neurodegeneration; p coumaric acid; Type 2 diabetes

Indexed keywords

GALLIC ACID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PARA COUMARIC ACID; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR; ANTIOXIDANT; COUMARIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIPPOCAMPUS; INFLAMMATION; INSULIN BLOOD LEVEL; MALE; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; COUMARIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GALLIC ACID; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS;

EID: 85020096097     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-017-0039-8     Document Type: Article

References (52)

1. Abbott CA, Malik RA, van Ross ER et al (2011) Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care 34:2220–2224
2. Alamed J, Chaiyasit W, McClements DJ et al (2009) Relationships between free radical scavenging and antioxidant activity in foods. J Agric Food Chem 57:2969–2976
3. Alvarez-Nölting R, Arnal E, Barcia JM et al (2012) Protection by DHA of early hippocampal changes in diabetes: possible role of CREB and NF-κB. Neurochem Res 37(1):105–115
4. Ambika S, Saravanan R, Thirumavalavan K (2013) Antidiabetic and antihyperlipidemic effect of p-hydroxycinnamic acid on streptozotocin-induced diabetic Wistar rats. Biomed Aging Pathol 3(4):253–257
5. Bahadoran Z, Mirmiran P, Azizi F (2013) Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 12:43. doi:10.1186/2251-6581-12-43
6. Bancroft JD, Stevens A (2008) Theory and practice of histological techniques, 6th edn. Chruchill Liveingstone, Edinburgh, pp 126–127
7. Beutler E, Duron O, Kelly BM (1963) Improved method for determination of blood glutathione. J Lab Clin Med 61:882–888
8. Biessels GJ, van der Heide LP, Kamal A et al (2002) Ageing and diabetes: implications for brain function. Eur J Pharmacol 441:1–14
9. Bisse E, Abraham EC (1985) New less temperature-sensitive micro-chromatographic method for the separation and quantitation of glycosylated hemoglobins using a non-cyanide buffer system. J Chromatogr B Biomed Sci Appl 344:81–91
10. Brands MW, Bell TD, Gibson B (2004) Nitric oxide may prevent hypertension early in diabetes by counteracting renal actions of superoxide. Hypertension 43(1):57–63
11. Calisti L, Tognetti S (2004) Measure of glycosylated hemoglobin. Acta Biomed Ateneo Parmense 76:59–62
12. Chatzigeorgiou A, Halapas A, Kalafatakis K et al (2009) The use of animal models in the study of diabetes mellitus. In Vivo 23:245–258
13. Choi J, Chandrasekaran K, Demarest TG et al (2014) Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity. Ann Clin Transl Neurol 1(8):589–604
14. Cohen G, Dembiec D, Marcus J (1970) Measurement of catalase activity in tissue extracts. Anal Biochem 34:30–38
15. de la Monte SM (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease. Curr Alzheimer Res 9(1):35–66
16. Dugan LL, Sensi SL, Canzoniero LM et al (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15(10):6377–6388
17. Foghi K, Ahmadpour S (2014) Diabetes mellitus type 1 and neuronal degeneration in ventral and dorsal hippocampus. Iran J Pathol 9(1):33–37
18. Gold SM, Dziobek I, Sweat V et al (2007) Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50(4):711–719
19. Golembewski EK, Wales SQ, Aurelian L et al (2007) The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity. Exp Neurol 203(2):381–393
20. Guven M, Bozkurt AA, Akman T et al (2015) Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia. Iran J Basic Med Sci 18:356–363
21. Haffner SM, Greenberg AS, Weston WM et al (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106:679–684
22. Hong SY, Jeong WS, Jun M (2012) Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules 17:10831–10845
23. IBM Corp (2011) IBM SPSS statistics for windows, version 20.0. IBM Corp, Armonk
24. Jafari AI, Sankian M, Ahmadpour S et al (2008) Evaluation of Bcl-2 family gene expression and caspase-3 activity in hippocampus STZ-induced diabetic rats. Exp Diabetes Res 638467:1–6
25. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3(6):614–620
26. Latha RC, Daisy P (2011) Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chem Biol Interact 189(1):112–118
27. Ma J, Luo XD, Protiva P et al (2003) Bioactive novel polyphenols from the fruit of Manilkara zapota (sapodilla). J Nat Prod 66:983–986
28. Mannervik B, Guthenberg C (1981) Glutathione transferase (human placenta). Methods Enzymol 77:231–235
29. Mansouri MT, Naghizadeh B, Ghorbanzadeh B et al (2013) Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats. Pharmacol Biochem Behav 111:90–96
30. Marklund S, Marklund G (1974) Involvement of superoxide anion radical in the autooxidation of pyrogallol and convenient assay for superoxide dismutase. Eur J Biochem 47:469–474
31. Masiello P, Broca C, Gross R et al (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224–229
32. Matkovics B, Sasvari M, Kotorman M et al (1998) Further prove on oxidative stress in alloxan diabetic rat tissues. Acta Physiol Hung 85:183–192
33. Muriach M, Bosch-Morell F, Alexander G et al (2006) Lutein effect on retina and hippocampus of diabetic mice. Free Radic Biol Med 41(6):979–984
34. Narayan KM, Gregg EW, Fagot-Campagna A et al (2000) Diabetes—a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 50:S77–S84
35. Oyagbemi AA, Omobowale TO, Saba AB et al (2016) Gallic acid ameliorates cyclophosphamide-induced neurotoxicity in Wistar rats through free radical scavenging activity and improvement in antioxidant defense system. J Diet Suppl 13(4):402–419
36. Patel SS, Parashar A, Udayabanu M (2015) Urtica dioica leaves modulates muscarinic cholinergic system in the hippocampus of streptozotocin-induced diabetic mice. Metab Brain Dis 30(3):803–811
37. 4 and Trigonella: a promising antidiabetic agent. Mol Cell Biochem 278:21–31
38. Preuss HG, Jarrel ST, Scheckenbach R et al (1998) Comparative effects of chromium, vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr 17(2):116–123
39. Prince M, Stanely P, Kumar MR et al (2011) Effects of gallic acid on brain lipid peroxide and lipid metabolism in streptozotocin-induced diabetic Wistar rats. J Biochem Mol Toxicol 25(2):101–107
40. Raza H, John A, Howarth FC (2015) Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain. Cell Physiol Biochem 35(3):1241–1251
41. Saibabu V, Fatima Z, Khan LA et al (2015) Therapeutic potential of dietary phenolic acids. Adv Pharmacol Sci 823539:1–10
42. Samarghandian S, Azimi-Nezhad M, Samini F (2014) Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. Biomed Res Int 920857:1–12
43. Sarkaki A, Fathimoghaddam H, Mansouri SM et al (2014) Gallic acid improves cognitive, hippocampal long-term potentiation deficits and brain damage induced by chronic cerebral hypoperfusion in rats. Pak J Biol Sci 17(8):978–990
44. Selvarajah D, Wilkinson ID, Davies J et al (2011) Central nervous system involvement in diabetic neuropathy. Curr Diab Rep 11(4):310–322
45. Sharma AK, Sharma A, Kumari R et al (2012) Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats. J Biomed Res 26(3):200–210
46. Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: an overview. Indian J Med Res 125(3):451–472
47. Thyagaraju BM, Muralidhara (2008) Ferulic acid supplements abrogate oxidative impairments in liver and testis in the streptozotocin-diabetic rat. Zool Sci 25:854–860
48. Trinder P (1969) Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6:24–27
49. Wohaieb SA, Godin DV (1987) Alterations in free radical tissue defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 36:1014–1018
50. Yoon JH, Youn K, Ho CT et al (2014) p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid 25-35-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells. J Agric Food Chem 62(21):4911–4916
51. Yun KJ, Koh DJ, Kim SH et al (2008) Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-κB inactivation. J Agric Food Chem 56:10265–10272
52. Zatalia SR, Sanusi H (2013) The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones 45:141–147